Rockwell Medical Bolsters Hemodialysis Offering with Single-Use Bicarbonate Cartridge

Rockwell Medical, Inc. (RMTI), a leading healthcare company specializing in hemodialysis products, has expanded its portfolio with the addition of a single-use bicarbonate cartridge. This new product, SteriLyte®, is set to enhance the company's competitive position in the hemodialysis market and drive growth. The introduction of SteriLyte® comes on the heels of a multi-year product purchase agreement with the world's leading provider of dialysis products and services, further solidifying Rockwell Medical's market presence.

The single-use bicarbonate cartridge offers several advantages over traditional liquid bicarbonate products. Firstly, it eliminates the need for on-site mixing and storage, reducing labor costs and storage space requirements. This convenience and ease of use can lead to improved efficiency and reduced waste, contributing to cost savings for dialysis providers. Additionally, the use of single-use bicarbonate cartridges can have a positive environmental impact by reducing the amount of plastic waste generated and lowering the carbon footprint associated with transportation and storage of liquid bicarbonate.

Rockwell Medical's strategic partnership with the global leader in dialysis services is expected to generate upwards of $10 million in net sales for the Company in 2025, with incremental price increases each subsequent year and an effective term of up to five years. This agreement not only validates Rockwell Medical's product quality but also strengthens its market position. The partnership demonstrates Rockwell Medical's ability to compete and succeed in the global market, further solidifying its market share.

The addition of the single-use bicarbonate cartridge to Rockwell Medical's product portfolio enhances the company's competitive position in the hemodialysis market by offering customers a more diverse range of products, cost savings, improved patient safety, reduced environmental impact, and potential for increased revenue. As the leading supplier of liquid bicarbonate in the United States and the only manufacturer capable of producing liquid bicarbonate at a scale supporting major U.S.-based dialysis providers, Rockwell Medical is well-positioned to capitalize on the growing demand for hemodialysis products and services.

In conclusion, the introduction of the single-use bicarbonate cartridge to Rockwell Medical's product portfolio is a strategic move that is expected to drive revenue growth and strengthen the company's market share in the hemodialysis concentrates sector. The multi-year agreement with a global leader in dialysis services further solidifies Rockwell Medical's market position and signals confidence in the company's products and services. As the demand for hemodialysis products and services continues to grow, Rockwell Medical is poised to capitalize on this opportunity and deliver value to its shareholders.